Eaton Vance Management Incyte Corp Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Incyte Corp stock. As of the latest transaction made, Eaton Vance Management holds 184,963 shares of INCY stock, worth $11.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
184,963
Previous 184,648
0.17%
Holding current value
$11.3 Million
Previous $14 Million
12.13%
% of portfolio
0.02%
Previous 0.02%
Shares
22 transactions
Others Institutions Holding INCY
# of Institutions
617Shares Held
215MCall Options Held
366KPut Options Held
445K-
Baker Bros. Advisors LP New York, NY36.2MShares$2.2 Billion26.1% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$1.41 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$1.38 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA15.4MShares$938 Million0.54% of portfolio
-
State Street Corp Boston, MA9.9MShares$603 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $13.5B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...